Korean J Radiol.  2025 Jan;26(1):10-28. 10.3348/kjr.2024.0963.

Radiofrequency Ablation for Recurrent Thyroid Cancers: 2025 Korean Society of Thyroid Radiology Guideline

Affiliations
  • 1Department of Radiology, Ajou University School of Medicine, Suwon, Republic of Korea
  • 2Department of Radiology, Yeouido St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
  • 3Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea
  • 4Department of Radiology, Soonchunhyang University Seoul Hospital, Seoul, Republic of Korea
  • 5Department of Radiology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Republic of Korea
  • 6Department of Radiology, Haeundae Sharing and Happiness Hospital, Busan, Republic of Korea
  • 7Department of Radiology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
  • 8Department of Radiology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea
  • 9Department of Radiology, Anam Hospital, Korea University College of Medicine, Seoul, Republic of Korea
  • 10Department of Korea, CHA Gangnam Medical Center, CHA University, Seoul, Republic of Korea
  • 11Department of Korea, Daejin Medical Center, Bundang Jesaeng General Hospital, Seongnam, Republic of Korea
  • 12Department of Korea and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
  • 13Department of Radiology, St. Vincent’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
  • 14Department of Radiology, National Cancer Center, Goyang, Republic of Korea
  • 15Department of Radiology, Ansan Hospital, Korea University College of Medicine, Ansan, Republic of Korea
  • 16Department of Radiology, Hanyang University College of Medicine, Hanyang University Hospital, Seoul, Republic of Korea
  • 17Department of Radiology and Thyroid Center, Daerim St. Mary’s Hospital, Seoul, Republic of Korea
  • 18Division for Healthcare Technology Assessment Research, National Evidence-based Healthcare Collaborating Agency, Seoul, Republic of Korea
  • 19Department of Radiology, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Republic of Korea

Abstract

Radiofrequency ablation (RFA) is a minimally invasive treatment modality used as an alternative to surgery in patients with benign thyroid nodules, recurrent thyroid cancers (RTCs), and primary thyroid microcarcinomas. The Korean Society of Thyroid Radiology (KSThR) initially developed recommendations for the optimal use of RFA for thyroid tumors in 2009 and revised them in 2012 and 2017. As new meaningful evidence has accumulated since 2017 and in response to a growing global interest in the use of RFA for treating malignant thyroid lesions, the task force committee members of the KSThR decided to update the guidelines on the use of RFA for the management of RTCs based on a comprehensive analysis of current literature and expert consensus.

Keyword

Thyroid; Ultrasound; Radiofrequency ablation; Thyroid recurrent cancers; Thyroid intervention
Full Text Links
  • KJR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2025 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr